BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28819854)

  • 1. Flow Cytometric Detection of Circulating Tumor Cells Using a Candidate Stem Cell Marker, p75 Neurotrophin Receptor (p75NTR).
    Okumura T; Yamaguchi T; Watanabe T; Nagata T; Shimada Y
    Methods Mol Biol; 2017; 1634():211-217. PubMed ID: 28819854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Relevance of a Candidate Stem Cell Marker, p75 Neurotrophin Receptor (p75NTR) Expression in Circulating Tumor Cells.
    Okumura T; Yamaguchi T; Watanabe T; Nagata T; Shimada Y
    Adv Exp Med Biol; 2017; 994():247-254. PubMed ID: 28560678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enumeration of Circulating Tumor Cells and Disseminated Tumor Cells in Blood and Bone Marrow by Immunomagnetic Enrichment and Flow Cytometry (IE/FC).
    Magbanua MJM; Solanki TI; Ordonez AD; Hsiao F; Park JW
    Methods Mol Biol; 2017; 1634():203-210. PubMed ID: 28819853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of circulating tumor cells by p75NTR expression in patients with esophageal cancer.
    Yamaguchi T; Okumura T; Hirano K; Watanabe T; Nagata T; Shimada Y; Tsukada K
    World J Surg Oncol; 2016 Feb; 14(1):40. PubMed ID: 26897248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced cancer stem cell properties of a mitotically quiescent subpopulation of p75NTR-positive cells in esophageal squamous cell carcinoma.
    Kojima H; Okumura T; Yamaguchi T; Miwa T; Shimada Y; Nagata T
    Int J Oncol; 2017 Jul; 51(1):49-62. PubMed ID: 28534989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p75 neurotrophin receptor expression is a characteristic of the mitotically quiescent cancer stem cell population present in esophageal squamous cell carcinoma.
    Yamaguchi T; Okumura T; Hirano K; Watanabe T; Nagata T; Shimada Y; Tsukada K
    Int J Oncol; 2016 May; 48(5):1943-54. PubMed ID: 26984177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated Microfluidic Filtration and Immunocytochemistry Detection System for Capture and Enumeration of Circulating Tumor Cells and Other Rare Cell Populations in Blood.
    Pugia M; Magbanua MJM; Park JW
    Methods Mol Biol; 2017; 1634():119-131. PubMed ID: 28819845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulatory Tumor Cells in Esophageal Adenocarcinoma.
    Gopalan V; Lam AK
    Methods Mol Biol; 2018; 1756():177-186. PubMed ID: 29600370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple multicolor flow cytometry protocol for detection and molecular characterization of circulating tumor cells in epithelial cancers.
    Hristozova T; Konschak R; Budach V; Tinhofer I
    Cytometry A; 2012 Jun; 81(6):489-95. PubMed ID: 22438318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Tumor Cells: Markers and Methodologies for Enrichment and Detection.
    Alvarez Cubero MJ; Lorente JA; Robles-Fernandez I; Rodriguez-Martinez A; Puche JL; Serrano MJ
    Methods Mol Biol; 2017; 1634():283-303. PubMed ID: 28819860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Separable Bilayer Microfiltration Device for Label-Free Enrichment of Viable Circulating Tumor Cells.
    Hao S; Nisic M; He H; Tai YC; Zheng SY
    Methods Mol Biol; 2017; 1634():81-91. PubMed ID: 28819842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p75 neurotrophin receptor: A potential surface marker of tongue squamous cell carcinoma stem cells.
    Tong D; Sun J; Huang P; Li M; Zhang F
    Mol Med Rep; 2017 May; 15(5):2521-2529. PubMed ID: 28447720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multispectral Imaging Analysis of Circulating Tumor Cells in Negatively Enriched Peripheral Blood Samples.
    Miller B; Lustberg M; Summers TA; Chalmers JJ
    Methods Mol Biol; 2017; 1634():219-234. PubMed ID: 28819855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The low-affinity nerve growth factor receptor p75NTR identifies a transient stem cell-like state in oral squamous cell carcinoma cells.
    Osman TA; Parajuli H; Sapkota D; Ahmed IA; Johannessen ACh; Costea DE
    J Oral Pathol Med; 2015 Jul; 44(6):410-9. PubMed ID: 25212757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RareCyte
    Werbin JL; Nordberg JJ; Tzucker J; Varshavskaya P; Stilwell JL; Kaldjian EP
    Methods Mol Biol; 2017; 1634():173-180. PubMed ID: 28819850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EpCAM-Independent Enrichment and Detection of Viable Circulating Tumor Cells Using the EPISPOT Assay.
    Soler A; Cayrefourcq L; Mazel M; Alix-Panabières C
    Methods Mol Biol; 2017; 1634():263-276. PubMed ID: 28819858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of CD271, a potential cancer stem cell marker associated with chemoresistance and metastatic capacity.
    Li S; Yue D; Chen X; Wang L; Li J; Ping Y; Gao Q; Wang D; Zhang T; Li F; Yang L; Huang L; Zhang Y
    Oncol Rep; 2015 Jan; 33(1):425-32. PubMed ID: 25351876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-renewal and chemotherapy resistance of p75NTR positive cells in esophageal squamous cell carcinomas.
    Huang SD; Yuan Y; Liu XH; Gong DJ; Bai CG; Wang F; Luo JH; Xu ZY
    BMC Cancer; 2009 Jan; 9():9. PubMed ID: 19134212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
    Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
    Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biological role of the low-affinity p75 neurotrophin receptor in esophageal squamous cell carcinoma.
    Okumura T; Tsunoda S; Mori Y; Ito T; Kikuchi K; Wang TC; Yasumoto S; Shimada Y
    Clin Cancer Res; 2006 Sep; 12(17):5096-103. PubMed ID: 16951226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.